Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Chengdu Kanghong Pharma
Welcome,
Profile
Billing
Logout
3 Products
3 Diseases
3 Products
28 Trials
310 News
«
1
2
3
4
5
6
7
8
9
||||
||||||
Lumitin
(conbercept) /
Chengdu Kanghong Pharma
Trial completion:
AURORA: A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD
(clinicaltrials.gov) - Feb 27, 2013
P2
, N=122, Completed,
Sponsor: Chengdu Kanghong Biotech Co.,Ltd.
Active, not recruiting --> Completed
||||||||||
Lumitin
(conbercept) /
Chengdu Kanghong Pharma
New P3 trial:
A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD
(clinicaltrials.gov) - Sep 18, 2011
P3
, N=125, Completed,
Sponsor: Chengdu Kanghong Biotech Co.,Ltd.